Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic

BACKGROUND: There are many safety concerns regarding the use of antithymocyte globulin (ATG) in kidney transplant recipients (KTRs) during the ongoing COVID-19 pandemic. Hereby, we present our recent experience with ATG administration both as induction therapy and as an anti-rejection treatment. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolonko, Aureliusz, Więcek, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556699/
https://www.ncbi.nlm.nih.gov/pubmed/34697282
http://dx.doi.org/10.12659/AOT.933001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556699/
https://www.ncbi.nlm.nih.gov/pubmed/34697282
http://dx.doi.org/10.12659/AOT.933001

Ejemplares similares